A recent study confirms that unprocessed beef can be part of a heart-healthy diet without raising cardiovascular disease risk ...

Our top content from the 100th annual American Heart Association (AHA) Scientific Sessions included exclusive expert insights ...

A recently published, comprehensive systematic review and meta-analysis has added to the growing body of evidence showing that beef can be enjoyed in a heart-healthy diet.

A recently published, comprehensive systematic review and meta-analysis has added to the growing body of evidence showing ...

Menarini Group announces positive topline data from pivotal phase 3 BROADWAY & TANDEM trials of Obicetrapib and FDC Obicetrapib with Ezetimibe 10 mg: Florence, Italy Wednesday, De ...

There was a 21% reduction in MACE, an exploratory endpoint, in the obicetrapib group vs placebo after 1 year. Obicetrapib reduced LDL-C in patients with atherosclerotic cardiovascular disease and/or ...

The findings hint at the potential need for serial measurements in patients who are being considered for Lp(a)-lowering therapies.

Researchers reveal the structural details of apoB100's interaction with LDL receptors, offering insights into LDL ...

THERE ARE MANY misconceptions about important cardiovascular metrics. Often people think their risk of heart disease and ...

The topline results from the Phase III trial found the treatment to be well tolerated with a reduction in low-density ...

lipoprotein(a), apolipoprotein B, and apolipoprotein A1, were also found to be consistent with previous clinical trials. Notably, there was a 21% reduction in major adverse cardiovascular events ...